News | April 01, 2026
Merck completes acquisition of JSR Life Sciences’ chromatography business
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
The inspection is now closed, and no regulatory action has been recommended
The funding will be spread over four years, with BXLS also eligible for regulatory and commercial milestones, plus royalties on worldwide sales
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
40+ most innovative startups with disruptive contributions across MedTech, Medical Devices, BioPharma, Cell and Gene Therapy, AI and ML, Nutraceuticals, and Biomarkers exhibited their cutting-edge solutions
Capital expenditure stood at Rs. 405 crore to date against a planned Rs. 700 crore for FY26
EYRA features intuitive software, automation readiness, and the ability to detect dozens of analytes simultaneously with minimal hands-on time
A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics
India in the Changing Landscape of Life-Sciences Research & Development
The company also reported significant progress toward its internally defined Sustainable Development Goals
Subscribe To Our Newsletter & Stay Updated
